23 unchanged sentences
According to the notices, neither Sandoz nor MSN have challenged BRUKINSA’s composition of matter patent, which remains intact in protecting BRUKINSA from generic competition until its expiration in 2034.
+Added: On August 15, 2024, the court entered a joint stipulation and order dismissing the suit against Sandoz.
+Added: The suit against MSN is currently stayed until November 14, 2024.
+Added: AbbVie Litigation
+Added: On September 6, 2024, AbbVie Inc.
+Added: filed a complaint in the U.S.
+Added: District Court for the Northern District of Illinois against the Company, one of its wholly-owned subsidiaries and an individual scientist, alleging misappropriation of trade secrets concerning the Company’s Bruton’s tyrosine kinase (“BTK”) degrader program, including the lead compound, BGB-16673.
+Added: The complaint seeks an unspecified amount of monetary damages, declaratory judgment, restitution and other equitable remedies.
+Added: The Company will vigorously defend against the claims and file its response to AbbVie’s complaint by December 19, 2024.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.